(Q73025001)
Statements
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy (English)
Brennan DC
Garlock KA
Lippmann BA
Buller RS
Gaudreault-Keener M
Lowell JA
Miller SB
Shenoy S
Howard TK